CSL Behring

CSL Behring is a global leader in plasma protein therapeutics. The company manufactures safe and effective plasma-derived and recombinant therapies for treating coagulation disorders, primary immune deficiencies, hereditary angioedema and inherited respiratory disease, and neurological disorders in certain markets. The company�s products are also used in cardiac surgery, organ transplantation, burn treatment and to prevent hemolytic disease of the newborn. CSL Behring is a subsidiary of CSL Limited (ASX:CSL), a biopharmaceutical company with headquarters in Melbourne, Australia. For more information: www.cslbehring-us.com.